Site Search
Search Results
New State Law Removing Cost Barriers to Colorectal Cancer Screenings Takes Effect January 1st
Sacramento, Calif . – December 31, 2021 – Beginning January 1 st , a state law will remove out-of-pocket cost-sharing for patients needing a colonoscopy following a positive non-invasive screening test. The new law also aligns the age to ... States Preventive Services Task Force (USPSTF) guidelines , currently at 45 years. Colorectal cancer is one of the few cancers that can be prevented through screenings. There are several cost-efficient, non-invasive, easily accessible and safe preventive screening test options ...
Governor Newsom’s Veto of Legislation to Expand Access to Biomarker Testing Fails Cancer Patients
... 912 – which was introduced by Senator Monique Limón (D-Santa Barbara) and sponsored by the American Cancer Society Cancer Action Network (ACS CAN) and the University of California – aimed to enable more Californians to benefit from biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better quality of life and potentially lower costs for cancer patients. The following is a statement from ACS CAN California Managing Director Jim Knox: ...
Sen. Susan Rubio, Asm. Mike Gipson Receive ‘Legislator of the Year’ Award for Championing Lifesaving Cancer Public Policies
Sacramento , Calif. – California State Senator Susan Rubio and Assemblymember Mike Gipson received the Legislator of the Year award, a prestigious honor bestowed by the American Cancer Society Cancer Action Network (ACS CAN) in recognition of their commitment to strong, evidence-based policies that improve public health and save lives from cancer. ... waste,” said ACS CAN California State Legislative Director Autumn J. Ogden-Smith. Asm. Gipson championed legislation to remove out-of-pocket cost-sharing for patients needing a colonoscopy following a positive non-invasive screening test, reducing barriers for patients to receive ...
California Assembly Committee Passes Legislation Requiring More Insurance Plans Cover Biomarker Testing Needed for Many Innovative Cancer Treatments
... Senate Bill 912 will enable more Californians to benefit from biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better quality of life and potentially lower costs for some cancer patients. But to determine if a patient will benefit from certain targeted therapies, doctors ... Ogden-Smith, California Legislative Director for the American Cancer Society Cancer Action Network (ACS CAN). “It’s imperative we dismantle cost barriers in order to address and help reduce health disparities.” Communities that have been under-resourced, including communities of ...
Cancer Advocates Urge California Governor to Sign Legislation Expanding Access to Biomarker Testing Needed for Many Innovative Treatments
... bipartisan support throughout the legislative process. Biomarker testing is a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better quality of life and potentially lower costs for some cancer patients. Specific biomarkers, which can be measured in blood, tissue or other biospecimens, ... medicine for helping extend and improve his life. “We urge Governor Newsom to sign this critical piece of legislation that will help dismantle cost barriers and bring the promise of precision medicine to more patients, regardless of their income, race or zip code,” stated Cala. ...
Senate Introduces Legislation to Increase Californians’ Access to Lifesaving Testing and Innovative Treatments
... Calif. — Today, State Senator Monique Limón (D-Santa Barbara) introduced Senate Bill 912 to increase access to biomarker testing, which can help determine the best treatment plan for a specific patient. The American Cancer Society Cancer Action Network (ACS CAN) and the University of California (UC) have teamed up to sponsor this important next step in ensuring cancer patients have access to precision medicine. The UC system ... coverage of biomarker testing more broadly, I have introduced SB 912. The bill will reduce barriers patients face when accessing timely care and cost of treatment. SB 912 will improve access to care, precision medicine, and will reduce overall healthcare costs by avoiding unnecessary ...
California Cancer Advocates Rally Virtually for Increased Access to Innovative Testing and Lifesaving Treatments
Sacramento, Calif. – American Cancer Society Cancer Action Network (ACS CAN) volunteers met virtually with state lawmakers Tuesday and urged them to pass legislation that would ensure comprehensive biomarker testing is ... testing is critical in accessing precision medicine, including targeted therapies that can lead to improved survivorship and better quality of life for cancer patients. “Every year – as part of California Cancer Action Day – cancer patients, survivors and advocates from across the ... medical centers are less likely to receive recommended biomarker testing. “We urge the legislature to pass this bill to help dismantle cost barriers and bring the promise of precision medicine to more cancer patients, regardless of their income, race or zip code,” said Autumn J. ...